Form 8-K - Current report:
SEC Accession No. 0001493152-26-034815
Filing Date
2026-07-27
Accepted
2026-07-27 16:30:22
Documents
12
Period of Report
2026-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48243
2 EX-10.1 ex10-1.htm EX-10.1 46149
  Complete submission text file 0001493152-26-034815.txt   272678

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gctk-20260722.xsd EX-101.SCH 3020
4 XBRL LABEL FILE gctk-20260722_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE gctk-20260722_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3181
Mailing Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070
Business Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070 972 (8) 675-7878
Glucotrack, Inc. (Filer) CIK: 0001506983 (see all company filings)

EIN.: 980668934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41141 | Film No.: 261206213
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)